These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 33682725)
21. Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers. Vilas D; Shaw LM; Taylor P; Berg D; Brockmann K; Aasly J; Marras C; Pont-Sunyer C; Ríos J; Marek K; Tolosa E Mov Disord; 2016 Jun; 31(6):906-14. PubMed ID: 27041685 [TBL] [Abstract][Full Text] [Related]
22. Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study. Mestre TA; Pont-Sunyer C; Kausar F; Visanji NP; Ghate T; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Kasten M; Wadia PM; Zadikoff C; Kumar P; de Bie RM; Thomsen T; Lang AE; Schüle B; Klein C; Tolosa E; Marras C Mov Disord; 2018 Jul; 33(6):960-965. PubMed ID: 29665080 [TBL] [Abstract][Full Text] [Related]
23. Motor subtypes and clinical characteristics in sporadic and genetic Parkinson's disease groups: analysis of the PPMI cohort. Jeong EH; Lee JY; Han SK; Song YS Front Neurol; 2023; 14():1276251. PubMed ID: 37954645 [TBL] [Abstract][Full Text] [Related]
24. Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease. Arora S; Visanji NP; Mestre TA; Tsanas A; AlDakheel A; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Lang AE; Little MA; Marras C J Parkinsons Dis; 2018; 8(4):503-510. PubMed ID: 30248062 [TBL] [Abstract][Full Text] [Related]
37. Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease? Anis S; Goldberg T; Shvueli E; Kozlov Y; Redlich Y; Lavi N; Lavie I; Sosero YL; Gan-Or Z; Ungar L; Zibly Z; Greenbaum L; Fay-Karmon T; Hassin-Baer S Parkinsonism Relat Disord; 2024 Jul; 124():106008. PubMed ID: 38242744 [TBL] [Abstract][Full Text] [Related]
38. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease. Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916 [TBL] [Abstract][Full Text] [Related]
39. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene. Somme JH; Molano Salazar A; Gonzalez A; Tijero B; Berganzo K; Lezcano E; Fernandez Martinez M; Zarranz JJ; Gómez-Esteban JC Parkinsonism Relat Disord; 2015 May; 21(5):494-9. PubMed ID: 25840672 [TBL] [Abstract][Full Text] [Related]
40. Association of Total Bilirubin with Motor Signs in Early Parkinson's Disease in LRRK2 Variant Carriers. Kazemi D; Hajishah H; Chadeganipour AS J Mol Neurosci; 2022 Nov; 72(11):2338-2344. PubMed ID: 36125733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]